Allurion Technologies (NYSE:ALUR) Announces Earnings Results, Misses Expectations By $2.00 EPS

Allurion Technologies (NYSE:ALUR) posted its quarterly earnings data on Wednesday. The company reported ($7.00) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($5.00) by ($2.00), Zacks reports. The firm had revenue of $5.59 million for the quarter, compared to the consensus estimate of $5.60 million. Allurion Technologies updated its FY 2025 guidance to EPS.

Allurion Technologies Price Performance

ALUR stock opened at $3.25 on Friday. The firm has a 50-day moving average of $4.01 and a 200 day moving average of $9.84. The company has a market cap of $15.57 million, a P/E ratio of -0.27 and a beta of -0.59. Allurion Technologies has a 1 year low of $2.15 and a 1 year high of $98.75.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on ALUR. Chardan Capital reaffirmed a “neutral” rating and issued a $2.50 price objective on shares of Allurion Technologies in a research note on Thursday. Roth Mkm reaffirmed a “buy” rating and issued a $16.00 price target on shares of Allurion Technologies in a research note on Friday, March 21st.

Allurion Technologies Company Profile

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.